These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37814826)

  • 1. Evaluation of 2,3-dihydroimidazo[2,1-
    Shahin AI; Zaraei SO; Alzuraiqi S; Abdulateef Z; Abbas NE; Al-Tel TH; El-Gamal MI
    Future Med Chem; 2023 Oct; 15(20):1885-1901. PubMed ID: 37814826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advance in oxazole-based medicinal chemistry.
    Zhang HZ; Zhao ZL; Zhou CH
    Eur J Med Chem; 2018 Jan; 144():444-492. PubMed ID: 29288945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and exploration of new classes of antitubercular agents: The optimization of oxazolines, oxazoles, thiazolines, thiazoles to imidazo[1,2-a]pyridines and isomeric 5,6-fused scaffolds.
    Moraski GC; Markley LD; Chang M; Cho S; Franzblau SG; Hwang CH; Boshoff H; Miller MJ
    Bioorg Med Chem; 2012 Apr; 20(7):2214-20. PubMed ID: 22391032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-Nitro-2,3-dihydroimidazo[2,1-b][1,3]thiazoles: Facile synthesis and comparative appraisal against tuberculosis and neglected tropical diseases.
    Thompson AM; Blaser A; Palmer BD; Anderson RF; Shinde SS; Launay D; Chatelain E; Maes L; Franzblau SG; Wan B; Wang Y; Ma Z; Denny WA
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2583-2589. PubMed ID: 28462832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of oxazole scaffold: a patent review (2006-2017).
    Kaur R; Palta K; Kumar M; Bhargava M; Dahiya L
    Expert Opin Ther Pat; 2018 Nov; 28(11):783-812. PubMed ID: 30239247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.
    Sasaki H; Haraguchi Y; Itotani M; Kuroda H; Hashizume H; Tomishige T; Kawasaki M; Matsumoto M; Komatsu M; Tsubouchi H
    J Med Chem; 2006 Dec; 49(26):7854-60. PubMed ID: 17181168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Developments in Oxazole Derivatives as Anticancer Agents: Review on Synthetic Strategies, Mechanism of Action and SAR Studies.
    Kulkarni S; Kaur K; Jaitak V
    Anticancer Agents Med Chem; 2022; 22(10):1859-1882. PubMed ID: 34525925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxazole-Based Compounds As Anticancer Agents.
    Chiacchio MA; Lanza G; Chiacchio U; Giofrè SV; Romeo R; Iannazzo D; Legnani L
    Curr Med Chem; 2019; 26(41):7337-7371. PubMed ID: 30501590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repositioning Antitubercular 6-Nitro-2,3-dihydroimidazo[2,1-b][1,3]oxazoles for Neglected Tropical Diseases: Structure-Activity Studies on a Preclinical Candidate for Visceral Leishmaniasis.
    Thompson AM; O'Connor PD; Blaser A; Yardley V; Maes L; Gupta S; Launay D; Martin D; Franzblau SG; Wan B; Wang Y; Ma Z; Denny WA
    J Med Chem; 2016 Mar; 59(6):2530-50. PubMed ID: 26901446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antimycobacterial screening of new thiazolyl-oxazole derivatives.
    Abhale YK; Sasane AV; Chavan AP; Shekh SH; Deshmukh KK; Bhansali S; Nawale L; Sarkar D; Mhaske PC
    Eur J Med Chem; 2017 May; 132():333-340. PubMed ID: 28411559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Scenario of 1,3-oxazole Derivatives for Anticancer Activity.
    Yan X; Wen J; Zhou L; Fan L; Wang X; Xu Z
    Curr Top Med Chem; 2020; 20(21):1916-1937. PubMed ID: 32579505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of new imidazo[2,1-b][1,3,4]thiadiazole-benzimidazole derivatives.
    Ramprasad J; Nayak N; Dalimba U; Yogeeswari P; Sriram D; Peethambar SK; Achur R; Kumar HS
    Eur J Med Chem; 2015 May; 95():49-63. PubMed ID: 25794789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and evaluation of novel nitrodihydroimidazooxazoles as promising anti-tuberculosis agents.
    Tao X; Gao C; Huang ZG; Luo W; Liu KL; Peng CT; Ding CZ; Li J; Chen SH; Yu LT
    Bioorg Med Chem Lett; 2019 Sep; 29(17):2511-2515. PubMed ID: 31353295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of the disubstituted oxazole analogues as a novel class anti-tuberculotic agents against MDR- and XDR-MTB.
    Li D; Gao N; Zhu N; Lin Y; Li Y; Chen M; You X; Lu Y; Wan K; Jiang JD; Jiang W; Si S
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5178-81. PubMed ID: 26459210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiproliferative activity of thiazole and oxazole derivatives: A systematic review of in vitro and in vivo studies.
    Guerrero-Pepinosa NY; Cardona-Trujillo MC; Garzón-Castaño SC; Veloza LA; Sepúlveda-Arias JC
    Biomed Pharmacother; 2021 Jun; 138():111495. PubMed ID: 33765586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and Metabolism of Delamanid, a Novel Anti-Tuberculosis Drug, in Animals and Humans: Importance of Albumin Metabolism In Vivo.
    Sasahara K; Shimokawa Y; Hirao Y; Koyama N; Kitano K; Shibata M; Umehara K
    Drug Metab Dispos; 2015 Aug; 43(8):1267-76. PubMed ID: 26055620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of anti-tubercular and antibacterial activities of new 4-(2,6-dichlorobenzyloxy)phenyl thiazole, oxazole and imidazole derivatives. Part 2.
    Lu X; Liu X; Wan B; Franzblau SG; Chen L; Zhou C; You Q
    Eur J Med Chem; 2012 Mar; 49():164-71. PubMed ID: 22264895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and in vitro evaluation of new 5-substituted 6-nitroimidazooxazoles as antikinetoplastid agents.
    Mathias F; Cohen A; Kabri Y; Negrão NW; Crozet MD; Docampo R; Azas N; Vanelle P
    Eur J Med Chem; 2020 Apr; 191():112146. PubMed ID: 32088496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances in the Synthesis of Oxazole-Based Molecules via van Leusen Oxazole Synthesis.
    Zheng X; Liu W; Zhang D
    Molecules; 2020 Mar; 25(7):. PubMed ID: 32244317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and anticancer activity of imidazo[2,1-b]oxazole-based RAF kinase inhibitors.
    Abdel-Maksoud MS; Ammar UM; El-Gamal MI; Gamal El-Din MM; Mersal KI; Ali EMH; Yoo KH; Lee KT; Oh CH
    Bioorg Chem; 2019 Dec; 93():103349. PubMed ID: 31627060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.